The Anti-inflammatory Effects of HMGB1 Blockades in a Mouse Model of Cutaneous Vasculitis
Overview
Affiliations
In our previous study, we have found increased serum levels of HMGB1 in patients with Henoch- Schonlein purpura (HSP), allergic vasculitis (AV), and urticarial vasculitis (UV) and altered HMGB1 distribution in lesional skin in patients with HSP. HMGB1 plays a pro-inflammatory role in the pathogenesis of HSP. To further investigate the role of HMGB1 in the pathogenic mechanism of vasculitis, we investigated the anti-inflammatory effects of HMGB1 blockades (including anti-HMGB1 mAb and glycyrrhizin) in a mouse model of a cutaneous reverse passive Arthus (RPA) reaction. A total of 36 balb/c mice were randomly divided into four groups: the control group, IC model group, HMGB1 monoclonal antibody (anti-HMGB1-mAb) group and the glycyrrhizin group, with nine mice in each group. A cutaneous RPA reaction mouse model was established by injections of the OVA antibody and the OVA antigen. Mice of the anti-HMGB1-mAb group and glycyrrhizin group were pre-treated with anti-HMGB1 mAb or glycyrrhizin, respectively, before the RPA reaction. Our results indicated that HMGB1 blockades (anti-HMGB1 mAb and glycyrrhizin) obviously extenuated the severity of vasculitis skin damage and improved the histological evolvement of inflammatory cells infiltration, vascular fibroid necrosis, and vasodilation in a cutaneous RPA reaction mouse model. In addition, HMGB1 blockades reduced the infiltration of neutrophils, DCs, and T cells and decreased the mRNA expression of IL-6 and CCL5 in skin lesions in the cutaneous RPA reaction mouse model. We suggest that HMGB1 blockades may represent a new direction for the treatment of cutaneous vasculitis.
Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives.
Wei G, Pan Y, Wang J, Xiong X, He Y, Xu J Clin Cosmet Investig Dermatol. 2022; 15:2177-2186.
PMID: 36267690 PMC: 9576603. DOI: 10.2147/CCID.S381432.
Casciaro M, Di Salvo E, Gangemi S Biomolecules. 2022; 12(1).
PMID: 35053208 PMC: 8774071. DOI: 10.3390/biom12010060.
Yao W, Wang J, Zhu L, Jia X, Xu L, Tian X Front Oncol. 2021; 11:761346.
PMID: 34820329 PMC: 8606580. DOI: 10.3389/fonc.2021.761346.
Kam N, Wu K, Dai W, Wang Y, Yan L, Shakya R Angiogenesis. 2021; 25(2):181-203.
PMID: 34617194 PMC: 8494172. DOI: 10.1007/s10456-021-09819-0.
The Immune Tolerance Role of the HMGB1-RAGE Axis.
Watanabe H, Son M Cells. 2021; 10(3).
PMID: 33807604 PMC: 8001022. DOI: 10.3390/cells10030564.